chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Allergic reaction; itchy rash on legs that started above the knees/both arms on the outside of the arm; Burn; Dry skin; Eczema; This case was reported by a consumer via call center representative and described the occurrence of allergic reaction in a 58-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of injection site pain (received 1st dose on 18th April 2018, refer case US2019GSK104673).   On 12th June 2018, the patient received the 2nd dose of Shingrix (intramuscular). In August 2018, less than a year after receiving Shingrix, the patient experienced allergic reaction, itchy rash, burning sensation, dry skin and eczema. The patient was treated with medication unknown (Cream (Medication Unknown)). On an unknown date, the outcome of the allergic reaction, itchy rash, burning sensation, dry skin and eczema were not recovered/not resolved.   It was unknown if the reporter considered the allergic reaction, itchy rash, burning sensation, dry skin and eczema to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix dose and she developed a itchy rash on both legs that started above the knees and went into the inner thighs. At the same time, she also had an itchy rash that extended the length of both arms on the outside of the arm.   She describes that the rash runs along a nerve line. She saw a physician at a free clinic and was told she had an allergic reaction with some dry skin and eczema. The rash resolved and then restarted again. She said that she still has it but now it was getting worse. She has tried multiple creams and they only make it worse, causing the rash to itch more and burn. She said the rash on her legs looks horrible. The reporter did not consent to follow up. The reporter was unable to obtain additional information.
Shingles; Thought I was gonna die; so weak couldn't get in and out of bed; fever 102; pain through my whole body; no appetite; This case was reported by a consumer via and described the occurrence of shingles in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced shingles, impending doom, weakness, fever, appetite absent and general body pain. On an unknown date, the outcome of the shingles, impending doom, weakness, fever, appetite absent and general body pain were recovered/resolved.   It was unknown if the reporter considered the shingles, impending doom, weakness, fever, appetite absent and general body pain to be related to Shingles vaccine.  Additional details were provided as follows: The patient self-reported the case. The patient got shingles which was not bad at all. The patient got most awful reaction. The patient thought he/she was going to died. The patient was so weak and could not get in and out of bed. The patient had fever and body temperature was recorded as 102 degree F. The patient experienced no appetite for 3 days and had pain through whole body unlike anything he/she experienced. The patient had the same reaction with the booster dose, refer case US2021AMR179531.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR179531:Same reporter
I had the vaccine shot at around 8:30 am on 4/15/21 and I was ok after the 15 mins they made me wait. I had some general achiness and thats about it for the first 2 days. Then at about midnight on 4/17/21 before I went to bed, I noticed my arm was a little sore. I looked at it and it was red and swollen. There is a spot about 2 inches down my arm from the injection site. The spot is swollen and sore and a little itchy. It is about 2 or 3 inches in diameter. I have had it that for about 10 hours, that I am aware of.
Initial misuse report received from a healthcare professional on 30 October 2013 and at agency on 21 March 2014. A 14-year-old patient of unknown gender had received FLUZONE INTRADERMAL. The patient received FLUZONE at an incorrect age. No adverse event was reported. The list of documents held by sender: None.
On the evening of administration, the site was sore as would be expected. Twenty hours post injection, I developed headache, 8/10 pain, with body aches and stiff neck on left side. Left arm swelled and watch at wrist became tight. A raised, painful erythematous swelling 6 inches long in circumference and 3 inches high raised around my upper arm about 2 inches below the injection site. The injection site was not unusually red or raised. The red swollen area is around the circumference of my arm on the lateral aspect, not encircling completely to the inner aspect of my arm.
No adverse reaction at this time. Child 4 months old. Vaccine given outside of recommended age range.
End of first day, I was having body aches and a sore arm. Body aches, chills and night sweats occurred for first 48 hours. 1/28, noticed I had a tender spot on the  left side of my neck. Tender spot is swollen gland or lymph node. On 1/30/21 woke up with left half of back of my throat swollen shut. Took ibuprofen and Benadryl and swelling went down half way.
Patient reported to pharmacy on 10/19/18 that her left deltoid has been extremely sore since 9/28/18 (day after flu vaccine was administered). Patient reports using ibuprofen for 1 week without resolution of soreness.
1800 - left shoulder ache started 2200- Took Motrin 200mg preventative at bedtime 0430 (9/27/19)- extreme pain upon movement left shoulder, ache entire shoulder area, bone hurts to touch, no redness or swelling 0700- drive to work with left arm  held to body, feels like  knife stabbing into left shoulder joint. 0730: Seen in Employee health, ice applied to left shoulder, No redness or swelling present,;advised 800 mg  every 8 hours, for next day; sent home from work. 9/28/19- had extreme pain upon movement in left shoulder until 1400 - then eased up.  9/30/19 Able to work without pain- still has some bone tenderness
Faint erythema medially leading down to elbow where there is brighter erythema and swelling, warm to touch. Diagnosed cellulitis.
Swelling in their left foot; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Swelling in their left foot) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027L20A and 013M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In January 2021, the patient experienced PERIPHERAL SWELLING (Swelling in their left foot). At the time of the report, PERIPHERAL SWELLING (Swelling in their left foot) had not resolved.            No Concomitant medication were reported.  No treatment medication were reported.  Patient has seen several doctors, and X-rays and ultrasound studies were performed but no explanations was found. Patient is concerned about medical expenses. Patient state they do not take any medication regularly.
I am pretty sure they gave the shot in my tricep area. I do know that it was definitely not in the CDC recommended area.  I contacted the facility and the Owner/Doctor told me that the shot could go into any muscle but I am not sure that is true...
Moderna COVID-19 Vaccine EUA. Adverse side effects; lethargy, fever, chills, vomiting, blisters in throat/sore throat, fatigue.
This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itchy), PRURITUS (itching was really bad), RASH ERYTHEMATOUS (big red rash on her upper left arm), PARAESTHESIA (Prickling/Tingling sensation) and FLUSHING (Flushing) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 023M20A and 046A21A) for COVID-19 vaccination. The patient's past medical history included Hives, Rash and Red eye. Concurrent medical conditions included Allergy to chemicals NOS (Allergic to sulphur). Concomitant products included MULTIVITAMIN [VITAMINS NOS] for an unknown indication. On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Feb-2021, the patient experienced PRURITUS (itchy), PARAESTHESIA (Prickling/Tingling sensation) and FLUSHING (Flushing). On 23-Feb-2021, the patient experienced PRURITUS (itching was really bad) and RASH ERYTHEMATOUS (big red rash on her upper left arm). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency and HYDROCORTISONE (topical) for Itching and Redness, at an unspecified dose and frequency. On 23-Feb-2021, PRURITUS (itchy), PRURITUS (itching was really bad), PARAESTHESIA (Prickling/Tingling sensation) and FLUSHING (Flushing) had resolved. At the time of the report, RASH ERYTHEMATOUS (big red rash on her upper left arm) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered PRURITUS (itchy) to be possibly related. No further causality assessments were provided for PRURITUS (itching was really bad), RASH ERYTHEMATOUS (big red rash on her upper left arm), PARAESTHESIA (Prickling/Tingling sensation) and FLUSHING (Flushing).  Most recent FOLLOW-UP information incorporated above includes: On 14-Jul-2021: Follow up information was received: Included significant information such as new events, second dose information, Allery status, historical conditions and concomitant were added. Event outcome changed unknown to recovered.
Sore arm down to hand and armpit. Big red spot on my arm where injection was given. Keeps getting bigger with time. Itchy as well
swelling of left arm and shoulder from shoulder to below elbow, extreme itching  and rash, fatigue, headache, loss of appetite, low-grade fever.  This has continued for two weeks.
Outbreak of genital herpes shortly after both doses of the vaccine.  Hadn?t had outbreak in years.
Vaccine was expired for 35 days. Pt recieved second dose 6/21/2022, same lot number.  Both doses given inadvertently due to confusion in extended dates. vaccine stored in refrigerator and not ultra-cold. Used ultra-cold extended date instead of 10 week expiration date.
Red area on arm at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (Red area on arm at injection site) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination.     Concurrent medical conditions included Sulfonamide allergy (Hives, treated with Benadryl and they went away.). Concomitant products included LOVASTATIN for an unknown indication.    On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (Red area on arm at injection site). At the time of the report, VACCINATION SITE ERYTHEMA (Red area on arm at injection site) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment details were provided.   This case was linked to MOD-2021-263036 (Patient Link).
I am still having significant left shoulder pain one month after the administration. The injection was given very high, and I believe was administered into the bursa instead of the muscle. The pain is worse with palpating and lifting my arm up. I can do most activities, but have to take ibuprofen if I know I will be using my arms for a lot of physical activity. I know this will probably heal and recover eventually, but it is impacting my life  for now.
Pain in L shoulder/arm and tingling in L hand (at this time continuing 6 weeks post injection).
10 days after receiving the booster shot of Moderna vaccine, full body rash/hives started and still persisting after 6 days no matter how much Benadryl or Zyrtec is consumed.
female who presents with abdominal pain.  Patient reports she began having pain across the upper abdomen around 4:00 a.m. this morning.  She describes her pain as sharp and crampy.  Patient reports it did make her nauseous but she did not vomit.  Patient denies any constipation, diarrhea, melena, hematochezia, dysuria, or hematuria.  Patient denies any fevers or chills.
Pain behind left eye and left temple. Pain behind eye was severe but has subsided, now a dull ache off and on. Pain on left temple still present off and on. Light sensitivity, things seem brighter? Today, the 24th I am still having these symptoms.   There are patient threads such as this one where others have experienced the same eye issues from the Pfizer or Moderna vaccine: https://www.drugdiscoverytrends.com/6-questions-about-facial-swelling-and-covid-19-vaccines-answered/
Pt felt breast mass in Feb '21. All w/u neg  Had milt episodes breast pain.  Mastitis after her baby in '22 then dx with breast angiosarcoma. It is very very rare to be dx with this So young.
Went to urgent care and was diagnosed with vertigo. It's been 6 weeks and am still experiencing dizziness and light headedness.
Client complained of lightheadedness and feeling bad immediately after injection.  Whelps noted on chest and back.  BENADRYL 2 teaspoon by mouth and PRELONE 2 teaspoons by mouth.
Fever (101.4), nausea and vomiting, lump at site of injection
Shoulder pain - first reported to dr. at urgent care 12/20/2007. Marcaine injection 4/10/2009, Physical therapy May 2009. Ulnar nerve block June 2009. Second course of Physical Therapy Feb. 2011. Shoulder impingement. Subacromial decompression and burectomy performed Aug. 10, 2011.
Administrative deviation only; no adverse event resulted from this deviation.This patient received a  mixed series of COVID-19 vaccine (one dose of Moderna and one dose of Pfizer-box #4 reflects the date  of the second dose).The decision to administer a mixed series to the patient was due to an "exceptional  circumstance" stemming from the unavailability of the first vaccine product (Moderna) at the time the  second dose was due.We understand that although CDC provides considerations for a mixed series in  exceptional circumstances (such as a vaccine shortage, which the case here), a mixed series is still  considered an administration deviation that requires VAERS reporting.Note second vaccination date is  listed.
I got a UTI in the last part of July 2021. There is no reason for me to get a UTI and I have had them in the past but not like this one. I went to the emergency room for the UTI. Urgent care. They prescribed antibiotics. I got another about a month after that and it has gone away.
spinal cord inflammation causing drop foot, reflex deficiencies, back, hip leg and foot pain.  Numbness and nerve pain in leg and foot
Severe skin burning and irritation. Severely red/raw blotchy rash all over extremities. It started the day after the vaccine by the second day it has spread all down my legs and arms, and very painful.
Site: Redness at Injection Site-Mild, Systemic: pt bled but not profusely-Mild, Additional Details: After administration, pt was bleeding a good amount, with blood running down his arm. As I was gathering suppplies to tend to him, he jumped up and left the vaccination room, and proceeded to act like I didn't know what I was doing. Patient left with no further tending to, and blood smeared all over his arm by himself. Two children were vaxxed at same time with no incident.
Information has been received from a physician concerning a 12 year old female with allergies to Augmentin who on 10-OCT-2007, 17-JAN-2008 and 17-SEP-2008 was vaccinated IM 0.5 mL with the first (lot# 658554/0928U), second (lot# 658488/1264U) and third (lot# 660391/0063X) doses of GARDASIL. There was no concomitant medication. After the third vaccination, the patient developed muscle aches and "went berserk at home" on an unspecified date. The patient's mother called the physician on 30-MAR-2009 to report that the patient "went berserk" and was hospitalized in the "psych ward". The patient's symptoms persisted. Additional information has been requested. 4/20/09-records received-for DOS 3/27-4/3/09-DC DX:anxiety disorder NOS. Admitted for a period of explosive outburst earlier. Punished for not oing to school. Punched wall. Refuses to go to school, did not sleep at night verbally abusive, few epsiodes of physical aggression towards property. Screaming. Parent felt threatened.
Red rash, swelling, itching around the injection site. Very large surface area of the arm. Appeared 8 days after vaccine. Has not yet subsided
PT REPORTS SYMPTOMS STARTED THE NEXT DAY WITH A MIGRAINE IN THE MORNING, TOOK ALEVE AND A SUMATRIPTAN AS USUAL FOR TX. NOTICED LATER IN THE AFTERNOON THAT SHE WAS STARTING TO GET MUSCLE ACHES, BACK ACHE, NAUSEA, & MALAISE. THEN INJECTION SIDE RASH/HIVES ~2-3 INCHES AND SMALL PATCH RASH A LITTLE LOWER ON ARM. BUT NO FEVER OR OTHER SYMPTOMS. TWO DAYS LATER CALLED PHARMACY, TOLD TO TAKE A BENADRYL AND CALL DOCTOR.
BUE redness with swelling post immunization. Erythema measuring 8x9 cm at each site.
This spontaneous report as received from a medical assistant refers to a 18 years old patient, gender was not reported. On 21-AUG-2014, the patient was vaccinated with VAQTA lot # K007791, expiration date 22-AUG-2014 (dose, strength, route and frequency were not reported). Patient received improperly stored VAQTA exposed to 49F for 35 minutes. No adverse effects were reported. This is one of several reports from the same source. Additional information has been requested.
A non-serious spontaneous report of 7 month old infant was administered the H1N1 LAIV; asthma with symptom of wheezing; cough and runny nose was received from a nurse practitioner/health professional concerning a seven-month-old male subsequent to H1N1, Intranasal. The patient had a history of pneumonia with wheezing when the child was two-month-old. The patient was not taking any concomitant medications and also the patient had strong family history of asthma for both the mother and an aunt. On 15-Dec-2009, the patient received H1N1, Intranasal for an unknown indication. On 25-Dec-2009, ten days after the vaccination, the child developed a cough, runny nose, and wheezing, but he never developed a fever. No treatment was required. All the three events resolved without intervention 12-hours after their onset, on 26-Dec-2009. As reported on 18-Jan 2010, during the patient's baby check up it was found that the child had an ongoing reactive airway condition determined to be an asthma attack. The reporter did not know if it was an exacerbation of an unknown underlying condition of asthma, and was a precursor for the onset of this current asthma attack. No test were conducted and the event was determined by physical examination so as not to subject to child to unnecessary testing and radiation. The patient was prescribed albuterol meter dose inhaler (MDI), two puffs three times daily (TID) and four times daily as needed (PRN) with a holding air chamber. The reporter explained that since the child was found to have had an ongoing reactive airway condition determined to be asthma, the child had been referred back to his attending physician. At the time of this transfer, the child was stable and had done very well on the albuterol meter dose inhaler and antibiotic physician had prescribed for him. The outcome of 7 month old infant was administered H1N1 LAIV was considered to be resolved. The event of cough and runny nose were resolved on 26-Dec-2009 while the event of asthma with symptom of wheezing was resolved on an unknown date. Additional information was received on 08-Jan-2010 and incorporated into the narrative: new adverse events and additional information added in event description; patient's medical history; concomitant medication confirmed as none; outcome of the events. Additional information was received on 18-Jan-2010 and incorporated into the narrative: Asthma attack was coded as new event and event of wheezing was removed as it was a symptom of asthma attack, medical history, event description and the outcome of events and other additional information reporters phone no. Additional information was received on 08-Feb-2010 and incorporated into the narrative: Changed event verbatim, event details with treatment and outcome of the asthma event and additional information added is corrected contact no of the reporter.
Day 2 fever of 101 degrees F; severe chills; body aches; skin tenderness; Extreme arm pain in injection arm on day 1.; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 31Mar2021 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. Medical history included blood pressure high (HBP), high cholesterol, and penicillin allergy. Concomitant medications included venlafaxine hydrochloride (EFFEXOR), lamotrigine (LAMICTAL), cyanocobalamin (B12), cholecalciferol (D3), magnesium (MANUFACTURER UNKNOWN) and melatonin (MANUFACTURER UNKNOWN) all taken for an unknown indication and from an unknown date. The patient previously received codeine for an unknown indication and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ENG200), via an unspecified route of administration in the left arm on 09Mar2021 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021, the patient experienced extreme arm pain in injection arm on day 1. On 01Apr2021, on day 2 the patient experienced fever of 101 degrees Fahrenheit (F), severe chills, body aches and skin tenderness. It was reported that the symptoms had been lasted for approximately 24 hours. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of reported events. The clinical outcomes of the events extreme arm pain in injection arm, fever, severe chills, body aches and skin tenderness were recovered on an unknown date (reported as lasted for approximately 24 hours (in 2021)).   No follow-up attempts are needed. No further information is expected.
Varicella titer was obtained for pre-employment requirements. Results showed no immunity. Previous immunization documentation was received after the titer was run, showing one previous Varicella vaccine in 2016. Prospective employee was notified about the negative immunity and that a second Varicella was required per CDC recommendations. Status of pregnancy was discussed and employee wanted to delay the vaccine off until tested for pregnancy. Appointment was re-scheduled for the following week. Employee came in on 11/22/17 and status of pregnancy was asked again. She stated no and circled no on the VARIVAX consent form. Vaccine was administered on 11/22/17. On 12/7/18, employee contacted this office to state she should not have received the vaccine because she was pregnant. Referred to her OB provider for counseling. No adverse results as of yet. Unsure of gestation, but probably early in 1st trimester.